Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: Findings from IMPROVE HF

American Heart Journal

Volumn 163, Issue 1, 2012, Pages

  Wilcox, Jane E ^a   Fonarow, Gregg C ^b   Yancy, Clyde W ^a   Albert, Nancy M ^c   Curtis, Anne B ^d   Heywood, J Thomas ^e   Inge, Patches Johnson ^f   McBride, Mark L ^g   Mehra, Mandeep R ^g   O'Connor, Christopher M ^h   Reynolds, Dwight ⁱ   Walsh, Mary Norine ^j   Gheorghiade, Mihai ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e SCRIPPS CLINIC   (United States)

^f Outcome Sciences Inc   (United States)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^j St Vincent s Heart Center of Indiana   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN;

ARTICLE; CLINICAL ASSESSMENT; CLINICAL PRACTICE; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 83455172647     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.10.001     Document Type: Article

References (16)

1. D. Lloyd-Jones, R. Adams, and M. Carnethon Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 119 2009 480 486
2. S.A. Hunt, W.T. Abraham, and M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
3. S.A. Hunt, W.T. Abraham, and M.H. Chin ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society Circulation 112 2005 e154 e235
4. M. St John Sutton, M.A. Pfeffer, and L. Moye Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial Circulation 96 1997 3294 3299 (Pubitemid 27513397)
5. S.D. Solomon, H. Skali, and N.S. Anavekar Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction Circulation 111 2005 3411 3419 (Pubitemid 40923394)
6. L.J. Gula, G.J. Klein, and A.S. Hellkamp Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Am Heart J 156 2008 1196 1200
7. G.C. Fonarow, N.M. Albert, and A.B. Curtis Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) Circulation 122 2010 585 596
8. G.C. Fonarow, J.T. Heywood, and P.A. Heidenreich Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J 153 2007 1021 1028 (Pubitemid 46809844)
9. D. Bello, D.J. Shah, and G.M. Farah Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy Circulation 108 2003 1945 1953 (Pubitemid 37296539)
10. M.R. Bristow, E.M. Gilbert, and W.T. Abraham Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators Circulation 94 1996 2807 2816 (Pubitemid 26411745)
11. L.A. Pires, S. Ghio, and E.S. Chung Relationship between acute improvement in left ventricular function to 6-month outcomes after cardiac resynchronization therapy in patients with chronic heart failure Congest Heart Fail 17 2011 65 70
12. F.A. Chaudhry, A. Shah, and S. Bangalore Inotropic contractile reserve and response to cardiac resynchronization therapy in patients with markedly remodeled left ventricle J Am Soc Echocardiogr 24 2011 91 97
13. G. Cintron, G. Johnson, and G. Francis Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group Circulation 87 6 Suppl 1993 VI17 VI23
14. P.F. Binkley, A. Lesinski, and J.P. Ferguson Recovery of normal ventricular function in patients with dilated cardiomyopathy: predictors of an increasingly prevalent clinical event Am Heart J 155 2008 69 74 (Pubitemid 350234766)
15. M. Merlo, S.A. Pyxaras, and B. Pinamonti Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment J Am Coll Cardiol 57 2011 1468 1476
16. F.F. Seghatol, D.J. Shah, and S. Diluzio Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 93 2004 854 859 (Pubitemid 38429596)